Skip to content

Real world data collection and population-based analysis of incidence of patients with acute myeloid leukemia (AML).

Real world data collection and population-based analysis of incidence of patients with acute myeloid leukemia (AML).

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON22811
Enrollment
200
Registered
2016-10-06
Start date
2016-01-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Goal: to determine overall survival of AML patients in the province of Friesland (NL) and to determine whether overall survival is dependent on the factors mentioned. Early death will also be determined.

Interventions

none

Sponsors

Stichting HemoBase
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: retrospective observational population-based; all patients in Friesland

Exclusion criteria

Exclusion criteria: retrospective observational population-based; all patients in Friesland

Design outcomes

Primary

MeasureTime frame
none

Contacts

Public ContactM. Hoogendoorn

MCL Henri Dunantweg 2

m.hoogendoorn@znb.nl0582866666

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)